The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action.
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005493:Folic Acid Antagonists; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010961:Plasmodium / Q000201:enzymology; D010962:Plasmodium berghei / Q000187:drug effects; D013412:Sulfadimethoxine / Q000627:therapeutic use; D014227:Triazines / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity
D000962:Antimalarials; D005493:Folic Acid Antagonists; D014227:Triazines; D013412:Sulfadimethoxine; C007087:clociguanil